The Dermatology Drug Development Summit Europe returns for its 6th year as the premier industry forum dedicated to advancing ...

Lilly and Novartis have collectively pledged almost $3 billion to their partnerships with Isomorphic signed last year, which ...

Novo Nordisk's Ozempic has been shown to improve waking distance and quality of life in people with type 2 diabetes (T2D) and ...

Eli Lilly's gene-silencing drug lepodisiran has been shown to reduce lipoprotein (a) levels by more than 90% for at least six ...

But, of course, young people themselves need to be offered a place at the table to make the changes they need for their own ...

Dr Marks formally resigned from his post on 28th March and is due to step down on 5th April, and his resignation letter ...

Lilly said it is planning to request a re-examination of the CHMP's appraisal of Kisunla, pointing out that the drug has ...